DCF — FLOYD MEDICAL CENTER
Enterprise Value: $604.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$604.3M
Enterprise Value
$166.0M
PV of Cash Flows
$438.4M
PV of Terminal Value
$706.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $496.2M | $71.4M | 14.0% | $35.7M | $32.4M |
| Year 2 | $511.1M | $78.7M | 15.0% | $40.6M | $33.5M |
| Year 3 | $526.4M | $86.3M | 16.0% | $45.7M | $34.4M |
| Year 4 | $542.2M | $91.6M | 17.0% | $49.1M | $33.6M |
| Year 5 | $558.4M | $95.7M | 17.0% | $51.7M | $32.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $604.3M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$481.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13894963913052807
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5